Articles on physicians with business degrees, a popular diabetes drug, and alcohol as an antidepressant may not seem to have a lot in common, but they were popular on social media in 2016. The American Journal of Managed Care®(AJMC®) thanks everyone who is a part of the franchise’s various social media platforms and who shared, liked, and promoted original research, news, and more all year long.
If you aren’t a part of AJMC®’s social network, join now!
AJMC® Facebook
AJMC® Twitter
AJMC® LinkedIn
AJMC® Instagram
Evidence-Based Oncology™ Twitter
Evidence-Based Diabetes Management™ Twitter
These 5 articles had the most interest on social media networks.
5. When Doctors Go to Business School: Career Choices of Physician—MBAs
An analysis of physicians who graduated from Harvard Business School found the just half (49.3%) remained clinically active in some capacity. Even fewer (27.7%) said that clinical medicine was their primary professional role. The study found that the majority of physician—MBAs diverted from clinical activity. This article, which shed new light into the career outcomes of the growing number of physician–MBAs, was published in the June issue of AJMC®.
4. Bariatric Surgery Outperforms Drugs, Lifestyle Interventions in Reversing Diabetes in Study
Not only did the study in this article find that gastric bypass provides benefits beyond weight loss and can actually be more effective than diet and exercise when it comes to reversing type 2 diabetes in people with mild obesity, but the study found the surgery outperformed anti-diabetic drugs. Patients in the study also enjoyed cardiovascular benefits and a reduced risk of cancer.
3. Afrezza: Treating Diabetes in a Physiologic Manner
The September issue of Evidence-Based Diabetes Management™ explored Afrezza, a fast-acting inhaled insulin that has been popular with patients, but had a bad launch. This article highlighted the clinical advantages of Afrezza. Author R. Keith Campbell, MBA, BPharm, CDE, looked at the evidence from studies provided his own personal perspective as someone living with type 1 diabetes.
For more on the situation with Afrezza, check out “5 Things to Know About Afrezza.”
2. Hospital or Home: Building a Better US Maternity Care System (Katy B. Kozhimannil)
AJMC.com contributor Katy B. Kozhimannil, PhD, MPA, looked at a paper published in The New England Journal of Medicine and the debate about which is safer for moms and their babies: to give birth at a hospital or at another setting, such as a birth center or at home? In her article, she weighed the benefits and risks found in the study, and what the findings mean.
If you are interested in becoming an AJMC.com contributor, e-mail Laura Joszt at ljoszt@ajmc.com.
1. Study Finds Alcohol Creates Effects of Fast-Acting Antidepressant
Perhaps it comes as no surprise that an article looking at the effects of alcohol was popular on social media. While the idea that people self-medicated with alcohol to relieve symptoms of depression is not new, a new study looked at the biochemical path and was able to show alcohol produced the same effect being seen in newer rapid-acting antidepressants. Not only does alcohol’s effect on depression occur quickly, but it can last a full day.
Social Media Power: 2016's Most-Read Articles on Facebook, Twitter, and LinkedIn
Articles on physicians with business degrees, a popular diabetes drug, and alcohol as an antidepressant may not seem to have a lot in common, but they were popular on social media in 2016.
Articles on physicians with business degrees, a popular diabetes drug, and alcohol as an antidepressant may not seem to have a lot in common, but they were popular on social media in 2016. The American Journal of Managed Care®(AJMC®) thanks everyone who is a part of the franchise’s various social media platforms and who shared, liked, and promoted original research, news, and more all year long.
If you aren’t a part of AJMC®’s social network, join now!
AJMC® Facebook
AJMC® Twitter
AJMC® LinkedIn
AJMC® Instagram
Evidence-Based Oncology™ Twitter
Evidence-Based Diabetes Management™ Twitter
These 5 articles had the most interest on social media networks.
5. When Doctors Go to Business School: Career Choices of Physician—MBAs
An analysis of physicians who graduated from Harvard Business School found the just half (49.3%) remained clinically active in some capacity. Even fewer (27.7%) said that clinical medicine was their primary professional role. The study found that the majority of physician—MBAs diverted from clinical activity. This article, which shed new light into the career outcomes of the growing number of physician–MBAs, was published in the June issue of AJMC®.
4. Bariatric Surgery Outperforms Drugs, Lifestyle Interventions in Reversing Diabetes in Study
Not only did the study in this article find that gastric bypass provides benefits beyond weight loss and can actually be more effective than diet and exercise when it comes to reversing type 2 diabetes in people with mild obesity, but the study found the surgery outperformed anti-diabetic drugs. Patients in the study also enjoyed cardiovascular benefits and a reduced risk of cancer.
3. Afrezza: Treating Diabetes in a Physiologic Manner
The September issue of Evidence-Based Diabetes Management™ explored Afrezza, a fast-acting inhaled insulin that has been popular with patients, but had a bad launch. This article highlighted the clinical advantages of Afrezza. Author R. Keith Campbell, MBA, BPharm, CDE, looked at the evidence from studies provided his own personal perspective as someone living with type 1 diabetes.
For more on the situation with Afrezza, check out “5 Things to Know About Afrezza.”
2. Hospital or Home: Building a Better US Maternity Care System (Katy B. Kozhimannil)
AJMC.com contributor Katy B. Kozhimannil, PhD, MPA, looked at a paper published in The New England Journal of Medicine and the debate about which is safer for moms and their babies: to give birth at a hospital or at another setting, such as a birth center or at home? In her article, she weighed the benefits and risks found in the study, and what the findings mean.
If you are interested in becoming an AJMC.com contributor, e-mail Laura Joszt at ljoszt@ajmc.com.
1. Study Finds Alcohol Creates Effects of Fast-Acting Antidepressant
Perhaps it comes as no surprise that an article looking at the effects of alcohol was popular on social media. While the idea that people self-medicated with alcohol to relieve symptoms of depression is not new, a new study looked at the biochemical path and was able to show alcohol produced the same effect being seen in newer rapid-acting antidepressants. Not only does alcohol’s effect on depression occur quickly, but it can last a full day.
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
October 20th 2025The 7-mg and 14-mg oral semaglutide tablets are now indicated to reduce the risk of major adverse cardiovascular events in adults with diabetes.
Read More
Challenges, Opportunities in Implementing the MDPP: Melanie T. Turk, PhD, RN
October 21st 2025Melanie T. Turk, PhD, RN, discusses her study on nationwide challenges program suppliers face in implementing the Medicare Diabetes Prevention Program (MDPP).
Listen
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
October 13th 2025A recent study reveals significant barriers to GLP-1 RA access for diabetes and obesity patients, highlighting racial disparities and high costs.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Opportunities and Obstacles Associated With the Medicare Diabetes Prevention Program
October 3rd 2025This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.
Read More
Medicare Insulin Savings Model Cuts Costs, Boosts Access, Report Finds
September 26th 2025A RAND report shows Medicare’s 3-year insulin savings model cut costs, improved access for beneficiaries, and offers lessons for future drug pricing reforms.
Read More
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
October 20th 2025The 7-mg and 14-mg oral semaglutide tablets are now indicated to reduce the risk of major adverse cardiovascular events in adults with diabetes.
Read More
Challenges, Opportunities in Implementing the MDPP: Melanie T. Turk, PhD, RN
October 21st 2025Melanie T. Turk, PhD, RN, discusses her study on nationwide challenges program suppliers face in implementing the Medicare Diabetes Prevention Program (MDPP).
Listen
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
October 13th 2025A recent study reveals significant barriers to GLP-1 RA access for diabetes and obesity patients, highlighting racial disparities and high costs.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Opportunities and Obstacles Associated With the Medicare Diabetes Prevention Program
October 3rd 2025This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.
Read More
Medicare Insulin Savings Model Cuts Costs, Boosts Access, Report Finds
September 26th 2025A RAND report shows Medicare’s 3-year insulin savings model cut costs, improved access for beneficiaries, and offers lessons for future drug pricing reforms.
Read More